Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Details on test material:
- - Name of test material (as cited in study report): Gelb LD 6259 (No 08/0646-1)
- Physical state: solid/ sun yellow
- Analytical purity: Main component Gelb LD 6259: HPLC fingerprint at 230 and 400 nm: 87.6% and 89.1 area% , respectively. Free acid content: about 61.3 g/100g
- batch No.: 0817 VP 01
- Stability under test conditions: the stability under storage conditions over the study period was guaranteed by the sponsor, and the sponsor holds this responsibility
- Storage condition of test material: room temperature
- Other: the test substance was homogeneous by visual inspection, pH value: ca. 5 (undiluted test substance, moistened with water)
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH, Sandhofer Weg 7, 97633 Sulzfeld
- Age at study initiation: 6 – 12 weeks
- Weight at study initiation: 18.0 g – 20.5 g
- Housing: single housed and identified by cage cards (Makrolon cage, type II)
- Diet (e.g. ad libitum): Kliba-Labordiät (Maus / Ratte Haltung “GLP”), Provimi Kliba SA, Kaiseraugst, Basel, Switzerland, ad libitum
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: 7 days before the first test-substance application
ENVIRONMENTAL CONDITIONS
- Temperature (°C): fully air-conditioned rooms. Central air-conditioning guaranteed a range of 20 – 24°C
- Humidity (%): 30 – 70%
- Photoperiod (hrs dark / hrs light): 12 h / 12 h (6.00 a.m. – 6.00 p.m. / 6.00 p.m. – 6.00 a.m.)
Study design: in vivo (LLNA)
- Vehicle:
- propylene glycol
- Remarks:
- Reason for the vehicle: propylene glycol was used as the vehicle because good homogeneity of the preparation was achieved; Form of application: suspension.
- Concentration:
- 3%, 10% and 30% w/w preparations of the test substance in propylene glycol
- No. of animals per dose:
- 5 females per group
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: the 30% preparation was the maximum technically applicable concentration.
- Irritation: the high concentration was selected based on the presence of ear irritation in a pretest using a 30% preparation.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
Test group Treatment Number of animals Animal No
Control group 1 Vehicle: propylene glycol 5 1-5
Test group 2 Test substance 3% in propylene glycol 5 1-5
Test group 3 Test substance 10% in propylene glycol 5 1-5
Test group 4 Test substance 30% in propylene glycol 5 1-5
- Name of test method: LLNA
- Criteria used to consider a positive response:
The increase SI of cell count by a factor of ≥ 1.5 and/or of 3H-thymidine incorporation by a factor of ≥ 3 as compared to the concurrent vehicle control group is generally considered as indicating a sensitizing potential of a test substance.
If applicable, the EC (estimated concentration) leading to the respective SI values were calculated by linear or semi-logarithmical regression between the data points directly below and above the SI if possible or using the two nearest points below or above the SI.
The EC leading to the respective SI values were calculated by semi-logarithmical regression using all data points of the test groups because all concentrations induced effects above the cut-off SIs.
If a test substance does not elicit a biological relevant increase in cell count, 3H-thymidine incorporation but shows a clear concentration related increase in response, further investigation of the sensitization potential at higher concentrations should be considered.
TREATMENT PREPARATION AND ADMINISTRATION:
- Form of application: epicutaneous application (simulating dermal contact with the compound which is possible to occur under practical use conditions).
- Application volume: 25 μL per ear; on study day five (about 66 to 72 hours after the last application of test substance to the ears) the mice were injected intravenously with 20 μCi of 3H-thymidine in 250 μl of sterile saline into a tail vein.
- Site of application: dorsal part of both ears
- Frequency of application: 3 consecutive applications (day 0 – day 2) to the same application site.
TERMINAL PROCEDURE:
The animals were sacrificed on study day 5 about 5 hours after 3H-thymidine injection by cervical dislocation.
- Determination of ear weight: immediately after the death of each animal, the weight of the pooled punches was determined for each test group by punching a circular piece of tissue (diameter 0.8 cm) out of the apical part of each ear of all animals. These measurements serve for detecting a potential inflammatory ear swelling.
- Removal and weight determination of the lymph nodes: immediately after removal of the ear punches the left and right auricular lymph nodes were dissected. The weight of the pooled lymph nodes from both sides was determined for each animal.
- Preparation of cell suspension and determination of cell count: after weight determination, the pooled lymph nodes of each test group were stored in phosphate buffered saline in an icewater bath until further preparation. A single cell suspension was prepared as soon as possible after dissection by carefully passing all lymph nodes per test group through an iron mesh (mesh size 200 μm) into 40 mL of phosphate-buffered physiological saline. For determination of cell counts, an aliquot of each suspension was further diluted with in a ratio 1:500 and the cell count was determined.
- Measurement of 3Hthymidine incorporation of the lymph node cells: the remaining cell suspensions were washed twice with PBS and precipitated with 5% trichloro-acetic acid (TCA). Each precipitate was transferred to scintillation fluid and incorporation of 3H-thymidine into the cells was measured in a ß-scintillation counter. - Positive control substance(s):
- other: A concurrent positive control (reliability check) with a known sensitizer was not included into this study, but studies using the positive control substance Alpha-Hexylcinnamaldehyde are performed twice a year in the laboratory.
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- The test substance induced a concentration dependent response in the auricular lymph node cell counts, which was biologically relevant (increase to 1.5 fold or above of control value = stimulation index (SI) ≥ 1.5) when applied as 3%, 10% and 30% preparations in propylene glycol. There was a concentration dependent increase in lymph node weights as well.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: The increase of 3H-thymidine incorporation into the cells was concentration dependent and biologically relevant (increase above the cut off stimulation index of 3) at the above mentioned concentrations
Any other information on results incl. tables
- Ear weight
The 30% test-substance preparation caused some increase in ear weights (see figure below). The ears of the mice of test groups 2, 3 and 4 were minimally yellow discolored on study day 1, 2 and on the day of lymph node removal.
- Body weights
The expected body weight gain was generally observed in the course of the study.
- Other findings
The 30% test-substance preparation caused some increase in ear weights. The ears of the mice of test groups 2, 3 and 4 were minimally yellow discolored on study day 1, 2 and on the day of lymph node removal.
No further abnormalities or systemic toxicity were observed during general observation
Tables 1: Cell count; test group mean values and stimulation indice
Test group |
Treatment |
Cell counts |
|
[Counts/Lymp node pair] |
Stimulation index1 |
||
1 |
Vehicle propylene glycol |
6765333 |
1.00 |
2* |
3% propylene glycol |
12236667 |
1.81 |
3 |
10% propylene glycol |
13701333 |
2.03 |
4 |
30% propylene glycol |
20946667 |
3.10 |
* Calculation on basis of 4 animals, as one animal died during 3H-thymidine injection; 1test group x / test group 1 (vehicle control) |
Table 2: 3H-thymidine incorporation; test group mean values and stimulation indice
Test group |
Treatment |
³H-thymidine incorporation |
|
[DPM/Lymph Node Pair] |
Stimulation index1 |
||
1 |
Vehicle propylene glycol |
463.8 |
1.00 |
2* |
3% propylene glycol |
1727.7 |
3.73 |
3 |
10% propylene glycol |
2586.8 |
5.58 |
4 |
30% propylene glycol |
3256.2 |
7.02 |
* Calculation on basis of 4 animals, as one animal died during 3H-thymidine injection; 1test group x / test group 1 (vehicle control) |
Table 3: Lymph Node Weight; test group mean values and stimulation indice
Test group |
Treatment |
Lymph Node Weight |
|
[mg/Lymph Node Pair] |
Stimulation index1 |
||
1 |
Vehicle propylene glycol |
4.3 |
1.00 |
2* |
3% propylene glycol |
5.8 |
1.34 |
3 |
10% propylene glycol |
6.6 |
1.53 |
4 |
30% propylene glycol |
9.9 |
2.29 |
* Calculation on basis of 4 animals, as one animal died during 3H-thymidine injection; 1test group x / test group 1 (vehicle control) |
Table 3: Ear Weight; test group mean values and stimulation indice
Test group |
Treatment |
Ear Weight |
|
[mg/animal] |
Stimulation index1 |
||
1 |
Vehicle propylene glycol |
32.8 |
1.00 |
2* |
3% propylene glycol |
32.6 |
0.99 |
3 |
10% propylene glycol |
33.3 |
1.02 |
4 |
30% propylene glycol |
36.5 |
1.11 |
* Calculation on basis of 4 animals, as one animal died during 3H-thymidine injection; 1test group x / test group 1 (vehicle control) |
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.